Ata uhi

An Overview of Bimekizumab for the Treatment of Psoriatic Arthritis: The Evidence so Far

Daniel G Oliveira,1 Raquel Faria,2,3 Tiago Torres3,4 1Department of Internal Medicine, Centro Hospitalar e Universitário do Porto, Porto, Portugal; 2Clinical Immunology Unit (UIC), Centro Hospitalar e Universitário do Porto, Porto, Portugal; 3Unit for Multidisciplinary Research...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	G Oliveira D (Author), Faria R (Author), Torres T (Author)
Hōputu:	Pukapuka
I whakaputaina:	Dove Medical Press, 2021-03-01T00:00:00Z.
Ngā marau:	article
Urunga tuihono:	Connect to this object online.
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite

Deucravacitinib for the treatment of psoriatic arthritis: the evidence so far
mā: Ana Martins, me ētahi atu.
I whakaputaina: (2023)

Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential
mā: Chiricozzi A, me ētahi atu.
I whakaputaina: (2019)

Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential [Corrigendum]
mā: Chiricozzi A, me ētahi atu.
I whakaputaina: (2019)

Eczematous eruption during bimekizumab treatment in a psoriatic patient previously treated with secukinumab
mā: Gennaro Marco Falco, me ētahi atu.
I whakaputaina: (2024)

Bimekizumab in Biologics-Refractory Psoriatic Arthritis: A Real-Life Analysis from a Combined Dermatology-Rheumatology Clinic
mā: Zabotti A, me ētahi atu.
I whakaputaina: (2024)

So near yet so far away
mā: R. John Aitken, Ph.D
I whakaputaina: (2020)

Review of bimekizumab in the treatment of psoriasis
mā: Sindhuja Koppu, me ētahi atu.
I whakaputaina: (2022)

Evidence-based algorithm for diagnosis and assessment in psoriatic arthritis: results by Italian DElphi in psoriatic Arthritis (IDEA)
mā: G. Lapadula, me ētahi atu.
I whakaputaina: (2016)

Upadacitinib for the treatment of psoriatic arthritis
mā: Diogo Fonseca, me ētahi atu.
I whakaputaina: (2023)

Spotlight on afatinib and its potential in the treatment of squamous cell lung cancer: the evidence so far
mā: Xu Y, me ētahi atu.
I whakaputaina: (2016)

Antibiotic stewardship: So near yet so far
mā: Vinayak Patki
I whakaputaina: (2020)

AJIM - The Journey So Far....
mā: Shrikanth N Hegde
I whakaputaina: (2023)

Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge
mā: Ruggiero A, me ētahi atu.
I whakaputaina: (2022)

Bimekizumab: the new drug in the biologics armamentarium for psoriasis
mā: Egídio Freitas, me ētahi atu.
I whakaputaina: (2021)

CONVENTIONAL THERAPY OF PSORIATIC ARTHRITIS: EVIDENCE-BASED REVIEW
mā: E.R. Soriano, me ētahi atu.
I whakaputaina: (2011)

So Far and Yet so Close Frontier Cattle Ranching in Prairie Western Canada and the Northern Territory of Australia
I whakaputaina: (2015)

So Far and Yet so Close Frontier Cattle Ranching in Prairie Western Canada and the Northern Territory of Australia
I whakaputaina: (2015)

Metallothioneins in Earthworms: The Journey So Far
mā: Ogunlaja Aemere, me ētahi atu.
I whakaputaina: (2020)

Nail psoriasis: The journey so far
mā: Alka Dogra, me ētahi atu.
I whakaputaina: (2014)

Psoriasis and Psoriatic Arthritis in ChildhoodPsoriasis and Psoriatic Arthritis in Childhood
mā: Nikolay N. Murashkin, me ētahi atu.
I whakaputaina: (2020)

Current treatment options for psoriatic arthritis: spotlight on abatacept
mā: Ursini F, me ētahi atu.
I whakaputaina: (2018)

A Critical Appraisal of Gluten in Skin Disorders, the Evidence So Far, and Updated Recommendations
mā: Atreyo Chakraborty
I whakaputaina: (2024)

Tomato flu in children in India: What evidence do we have so far?
mā: Parimala Mohanty, me ētahi atu.
I whakaputaina: (2022)

Evidence generation to strategize India's response to HIV: Journey so far and challenges ahead
mā: Dandu Chandra Sekhar Reddy
I whakaputaina: (2020)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
mā: M. Rossini, me ētahi atu.
I whakaputaina: (2015)

Ustekinumab for the treatment of psoriatic arthritis: an update
mā: Davari P, me ētahi atu.
I whakaputaina: (2014)

Platelet-rich plasma: The journey so far !
mā: Akanksha Kaushik, me ētahi atu.
I whakaputaina: (2020)

DERMOSCOPY OF INFLAMMATORY CONDITIONS: THE JOURNEY SO FAR
mā: Balachandra S. Ankad, me ētahi atu.
I whakaputaina: (2017)

Dermoscopy in Skin of Color: The Journey So Far
mā: Enzo Errichetti, me ētahi atu.
I whakaputaina: (2023)

Mental health-a bridge not so far
mā: Lorraine Sherr
I whakaputaina: (2017)

Pharmacy education in Nigeria: The journey so far
mā: Joshua Ikoni Ogaji, me ētahi atu.
I whakaputaina: (2014)

Laquinimod in the treatment of multiple sclerosis: a review of the data so far
mā: Thöne J, me ētahi atu.
I whakaputaina: (2016)

IMAGING OF PSORIATIC ARTHRITIS
mā: S. D'Angelo, me ētahi atu.
I whakaputaina: (2011)

BIOLOGIC THERAPY OF PSORIATIC ARTHRITIS
mā: D.D. Gladman
I whakaputaina: (2011)

Influenza vaccination for all pregnant women? So far the less biased evidence does not favour it
mā: Alberto Donzelli
I whakaputaina: (2019)

Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far?
mā: Nils Helge Schebb, me ētahi atu.
I whakaputaina: (2022)

CLINICAL PRESENTATION OF PSORIATIC ARTHRITIS
mā: M. Atteno, me ētahi atu.
I whakaputaina: (2011)

Profile of certolizumab and its potential in the treatment of psoriatic arthritis
mā: Chimenti MS, me ētahi atu.
I whakaputaina: (2013)

Biomarkers and prognostic stratification in psoriatic arthritis
mā: R. Caporali, me ētahi atu.
I whakaputaina: (2012)

Psoriatic arthritis: treatment strategies using biologic agents
mā: C. Palazzi, me ētahi atu.
I whakaputaina: (2012)